Author Question: The nurse is caring for a patient on the neurological unit who is in status epilepticus. What ... (Read 61 times)

newbem

  • Hero Member
  • *****
  • Posts: 579
The nurse is caring for a patient on the neurological unit who is in status epilepticus. What medication does the nurse anticipate being given to halt the seizure?
 
  A) IV phenobarbital
  B) IV diazepam
  C) IV lidocaine
  D) Oral phenytoin

Question 2

In response to a patient's elevated blood glucose level, the nurse has administered a dose of insulin as ordered. The nurse understands that insulin results in a lowered level of blood glucose by:
 
  A) Breaking the molecular bonds in glucose molecules
  B) Stimulating thyroid hormone release and increasing metabolic needs
  C) Inhibiting the action of glucagon
  D) Facilitating glucose transport into body cells



ansleighelindsey

  • Sr. Member
  • ****
  • Posts: 364
Answer to Question 1

B

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library